07 August 2024
The state Circle of Kindness Foundation has begun forming a reserve of unregistered medicines in Russia to ensure uninterrupted treatment for children with orphan diseases, based on requests from regions and federal centers. The first drug procured is belumosudil, used to prevent chronic graft-versus-host disease. This batch will be sent to the R. M. Gorbacheva Research Institute and the N. N. Blokhin National Medical Research Center.
The Circle of Kindness Foundation was established in 2021 at the President of Russia’s initiative. Earlier, during the conference “Social Partnership in the interests of children with serious illnesses” in the Public Chamber of the Russian Federation, Alexander Tkachenko, the chairman of the Board of the Foundation, said that the Circle of Kindness was able to provide medicines to almost 5,000 children with severe and orphan diseases.
The fund can form a reserve for an indefinite number of children based on regional or federal medical center requests, coordinated with the chief freelance specialist of the Russian Ministry of Health.
PrintOctober 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
DSM Group predicts the Russian pharmaceutical market will grow by 10% annually
18 October 2024
An extra 6.1 billion rubles will be allocated for drug provision in 2025
18 October 2024
Pharmasyntez to build heparin production plant in Tatarstan
17 October 2024
17 October 2024